Playgon Games to Canvass Voluntary Lockup with Key Shareholders
Vancouver, BC – December 03 2020 – Playgon Games Inc. (TSXV:DEAL ) / ( OTCQB:PLGNF ) / ( Frankfurt:7CR) (“ Playgon ” or the “ Company ”) is pleased to update its shareholders and the investment community on the very positive feedback it has received. Over the past several weeks Playgon has been introducing […]
How An Ancient Medicine Is Taking On The $16 Trillion Pharmaceutical Industry
FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – December 3, 2020 – 2021 could be a big year for this soon-to-be $16-trillion biotech opportunity. More importantly, it could be a big year for companies pioneering a new form of therapy that could effectively treat the world’s #1 disability. It’s a disability that’s costing […]
Consolidation of Clinics, MDs and Hospitals into Integrated Systems is Accelerating
Palm Beach, FL – December 3, 2020 – 2020 will be a year that will not soon be forgotten across all aspects of everyday life… and also in the commercial sector… including healthcare. Especially healthcare some would say. While 2020 is a year of emotional and financial hardship for most healthcare systems, it’s also a […]
Global Market for Cannabinoid-Based Pharmaceuticals Expected to Reach $50 Billion by 2029
Palm Beach, FL – December 3, 2020 – The medical segment of the cannabis explosion over the last decade, has not always been in the forefront… but its day is coming. The revenues from cannabinoid-based pharmaceuticals is projected to rise over the next several years. Cannabis – also known as marijuana – contains active ingredients […]
Development of Advanced Novel AML Drugs Target Increasing Cases of Acute Myeloid Leukemia
Palm Beach, FL – December 3, 2020 – Acute myeloid leukemia (AML) is a rare and heterogeneous blood cancer with a poor overall prognosis. It affects predominantly older adults with a median age at diagnosis of 66 years but also includes about 15% of children from birth to 19 years of age diagnosed with leukemia […]
Moleculin To Present Antitumor Activity of Annamycin in Combination with Ara-C in AML at American Society for Hematology Annual Conference
Houston, TX – December 3, 2020 – Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that it will present animal data demonstrating highly improved activity against acute myeloid leukemia (“AML”) in combination with the […]
Rapid Therapeutic Selects Clinical Research Center to Start Clinical Trials Using its Proprietary CBD and CBG Formulation
Dallas, TX – December 03, 2020 — Rapid Therapeutic Science Laboratories, Inc. (OTCPK: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on employing FDA-approved Metered Dose Inhaler (MDI) technology to deliver cannabinoid compounds, such as CBD, CBG, and CBN, announced today that it has selected Accent Clinical Research Professionals, LLC ) (”ACCENT”) […]
